Volume 12 Issue 6
Nov.  2021
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2021  >  12(6): 754-760
Wang Huan, Zhou Wentao, Liu Jiaxin, et al. Application prospect of hemoglobin-based oxygen carrier in kidney transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(6): 754-760. doi: 10.3969/j.issn.1674-7445.2021.06.017
Citation: Wang Huan, Zhou Wentao, Liu Jiaxin, et al. Application prospect of hemoglobin-based oxygen carrier in kidney transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(6): 754-760. doi: 10.3969/j.issn.1674-7445.2021.06.017
shu

Application prospect of hemoglobin-based oxygen carrier in kidney transplantation

doi: 10.3969/j.issn.1674-7445.2021.06.017

  • Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu 610052, China

More Information
  • Corresponding author: Wang Hong, Email: smile9918@126.com
  • Received Date: 2021-07-01
  • Publish Date: 2021-11-15
    Abstract
  • High-quality donor organs is of significance for the success of organ transplantation. However, standard donors fail to meet the requirements of kidney transplantation due to the increasing quantity of patients with kidney failure. Marginal donor kidneys have been widely applied in clinical practice, which also poses challenges to the existing preservation methods of donor kidneys. Ischemia-reperfusion injury (IRI) is one of the critical factors affecting the early graft function after kidney transplantation. In addition, it exerts harmful effect upon the long-term survival of the graft. Current studies have demonstrated that hemoglobin-based oxygen carrier (HBOC) may reduce the IRI during kidney transplantation, effectively improve the preservation quality and prolong the preservation time of donor kidney. In this article, the research progress on HBOC in kidney transplantation was reviewed, aiming to provide reference for modifying the preservation method of donor kidney, improve the quality of donor kidney and enhance clinical prognosis of the recipients.

     

    • FullText(HTML)
  • loading
    • References(50)
  • [1]
    KALANTAR-ZADEH K, LI PK. Strategies to prevent kidney disease and its progression[J]. Nat Rev Nephrol, 2020, 16(3): 129-130. DOI: 10.1038/s41581-020-0253-1.
    [2]
    THOMPSON ER, CONNELLY C, ALI S, et al. Cell therapy during machine perfusion[J]. Transpl Int, 2021, 34(1): 49-58. DOI: 10.1111/tri.13780.
    [3]
    MIRSHEKAR-SYAHKAL B, SUMMERS D, BRADBURY LL, et al. Local expansion of donation after circulatory death kidney transplant activity improves waitlisted outcomes and addresses inequities of access to transplantation[J]. Am J Transplant, 2017, 17(2): 390-400. DOI: 10.1111/ajt.13968.
    [4]
    THUILLIER R, HAUET T. Impact of hypothermia and oxygen deprivation on the cytoskeleton in organ preservation models[J]. Biomed Res Int, 2018: 8926724. DOI: 10.1155/2018/8926724.
    [5]
    WONG G, TEIXEIRA-PINTO A, CHAPMAN JR, et al. The impact of total ischemic time, donor age and the pathway of donor death on graft outcomes after deceased donor kidney transplantation[J]. Transplantation, 2017, 101(6): 1152-1158. DOI: 10.1097/TP.0000000000001351.
    [6]
    TEJCHMAN K, SIEROCKA A, KOTOWSKI M, et al. Acid-base balance disorders during kidney preservation in cold ischemia[J]. Transplant Proc, 2020, 52(7): 2036-2042. DOI: 10.1016/j.transproceed.2020.01.099.
    [7]
    JING L, YAO L, ZHAO M, et al. Organ preservation: from the past to the future[J]. Acta Pharmacol Sin, 2018, 39(5): 845-857. DOI: 10.1038/aps.2017.182.
    [8]
    STEICHEN C, GIRAUD S, BON D, et al. Barriers and advances in kidney preservation[J]. Biomed Res Int, 2018: 9206257. DOI: 10.1155/2018/9206257.
    [9]
    ROSENBERGER C, ECKARDT KU. Oxygenation of the transplanted kidney[J]. Semin Nephrol, 2019, 39(6): 554-566. DOI: 10.1016/j.semnephrol.2019.10.005.
    [10]
    LEMAIRE F, SIGRIST S, DELPY E, et al. Beneficial effects of the novel marine oxygen carrier M101 during cold preservation of rat and human pancreas[J]. J Cell Mol Med, 2019, 23(12): 8025-8034. DOI: 10.1111/jcmm.14666.
    [11]
    中华医学会器官移植学分会. 供肾灌注、保存及修复技术操作规范(2019版)[J]. 器官移植, 2019, 10(5): 473-477. DOI: 10.3969/j.issn.1674-7445.2019.05.002.

    Branch of Organ Transplantation of Chinese Medical Association. Technical operation specification for perfusion, preservation and repair of donor kidney (2019 edition)[J]. Organ Transplant, 2019, 10(5): 473-477. DOI: 10.3969/j.issn.1674-7445.2019.05.002.
    [12]
    ABURAWI MM, FONTAN FM, KARIMIAN N, et al. Synthetic hemoglobin-based oxygen carriers are an acceptable alternative for packed red blood cells in normothermic kidney perfusion[J]. Am J Transplant, 2019, 19(10): 2814-2824. DOI: 10.1111/ajt.15375.
    [13]
    LAING RW, BHOGAL RH, WALLACE L, et al. The use of an acellular oxygen carrier in a human liver model of normothermic machine perfusion[J]. Transplantation, 2017, 101(11): 2746-2756. DOI: 10.1097/TP.0000000000001821.
    [14]
    VARNEY J, RIVERA A, DONG V, et al. Mini-review on the properties and possible applications of therapeutic oxygen carrier Hemarina-M101[J]. Transfus Apher Sci, 2021, 60(1): 103016. DOI: 10.1016/j.transci.2020.103016.
    [15]
    GIRAUD S, THUILLIER R, CAU J, et al. In vitro/ex vivo models for the study of ischemia reperfusion injury during kidney perfusion[J]. Int J Mol Sci, 2020, 21(21): 8156. DOI: 10.3390/ijms21218156.
    [16]
    HOSGOOD SA, NICHOLSON ML. Organ retrieval and preservation[J]. Surgery (Oxford), 2014, 32(7): 338-343.
    [17]
    HAN SJ, LEE HT. Mechanisms and therapeutic targets of ischemic acute kidney injury[J]. Kidney Res Clin Pract, 2019, 38(4): 427-440. DOI: 10.23876/j.krcp.19.062.
    [18]
    DARIUS T, GIANELLO P, VERGAUWEN M, et al. The effect on early renal function of various dynamic preservation strategies in a preclinical pig ischemia-reperfusion autotransplant model[J]. Am J Transplant, 2019, 19(3): 752-762. DOI: 10.1111/ajt.15100.
    [19]
    NICHOLSON ML, HOSGOOD SA. Renal transplantation after ex vivo normothermic perfusion: the first clinical study[J]. Am J Transplant, 2013, 13(5): 1246-1252. DOI: 10.1111/ajt.12179.
    [20]
    SHONAKA T, MATSUNO N, OBARA H, et al. Application of perfusate with human-derived oxygen carrier solution under subnormothermic machine perfusion for donation after cardiac death liver grafts in pigs[J]. Transplant Proc, 2018, 50(9): 2821-2825. DOI: 10.1016/j.transproceed.2018.02.184.
    [21]
    MINOR T, VON HORN C, PAUL A. Role of erythrocytes in short-term rewarming kidney perfusion after cold storage[J]. Artif Organs, 2019, 43(6): 584-592. DOI: 10.1111/aor.13403.
    [22]
    FLATMARK A, SLAATTELID O, WOXHOLT G. Gaseous persufflation during machine perfusion of human kidneys before transplantation[J]. Eur Surg Res, 1975, 7(2): 83-90. DOI: 10.1159/000127794.
    [23]
    KALENSKI J, MANCINA E, PASCHENDA P, et al. Comparison of aerobic preservation by venous systemic oxygen persufflation or oxygenated machine perfusion of warm-ischemia-damaged porcine kidneys[J]. Eur Surg Res, 2016, 57(1/2): 10-21. DOI: 10.1159/000444851.
    [24]
    THUILLIER R, DELPY E, MATILLON X, et al. Preventing acute kidney injury during transplantation: the application of novel oxygen carriers[J]. Expert Opin Investig Drugs, 2019, 28(7): 643-657. DOI: 10.1080/13543784.2019.1628217.
    [25]
    COPPOLINO G, LEONARDI G, ANDREUCCI M, et al. Oxidative stress and kidney function: a brief update[J]. Curr Pharm Des, 2018, 24(40): 4794-4799. DOI: 10.2174/1381612825666190112165206.
    [26]
    VASKO R. Peroxisomes and kidney injury[J]. Antioxid Redox Signal, 2016, 25(4): 217-231. DOI: 10.1089/ars.2016.6666.
    [27]
    SCHOLZ H, BOIVIN FJ, SCHMIDT-OTT KM, et al. Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection[J]. Nat Rev Nephrol, 2021, 17(5): 335-349. DOI: 10.1038/s41581-021-00394-7.
    [28]
    DUANN P, LIN PH. Mitochondria damage and kidney disease[J]. Adv Exp Med Biol, 2017, 982: 529-551. DOI: 10.1007/978-3-319-55330-6_27.
    [29]
    DELPECH PO, THUILLIER R, LE PAPE S, et al. Effects of warm ischaemia combined with cold preservation on the hypoxia-inducible factor 1α pathway in an experimental renal autotransplantation model[J]. Br J Surg, 2014, 101(13): 1739-1750. DOI: 10.1002/bjs.9611.
    [30]
    HALDAR R, GUPTA D, CHITRANSHI S, et al. Artificial blood: a futuristic dimension of modern day transfusion sciences[J]. Cardiovasc Hematol Agents Med Chem, 2019, 17(1): 11-16. DOI: 10.2174/1871525717666190617120045.
    [31]
    ALAYASH AI. Blood substitutes: why haven't we been more successful?[J]. Trends Biotechnol, 2014, 32(4): 177-185. DOI: 10.1016/j.tibtech.2014.02.006.
    [32]
    SEN GUPTA A. Hemoglobin-based oxygen carriers: current state-of-the-art and novel molecules[J]. Shock, 2019, 52(1S Suppl 1): 70-83. DOI: 10.1097/SHK.0000000000001009.
    [33]
    VRSELJA Z, DANIELE SG, SILBEREIS J, et al. Restoration of brain circulation and cellular functions hours post-mortem[J]. Nature, 2019, 568(7752): 336-343. DOI: 10.1038/s41586-019-1099-1.
    [34]
    SPAHN DR. Artificial oxygen carriers: a new future?[J]. Crit Care, 2018, 22(1): 46. DOI: 10.1186/s13054-018-1949-5.
    [35]
    KUZMIAK-GLANCY S, COVIAN R, FEMNOU AN, et al. Cardiac performance is limited by oxygen delivery to the mitochondria in the crystalloid-perfused working heart[J]. Am J Physiol Heart Circ Physiol, 2018, 314(4): H704-H715. DOI: 10.1152/ajpheart.00321.2017.
    [36]
    HOSGOOD SA, NICHOLSON ML. The role of perfluorocarbon in organ preservation[J]. Transplantation, 2010, 89(10): 1169-1175. DOI: 10.1097/TP.0b013e3181da6064.
    [37]
    HOSGOOD SA, MOHAMED IH, NICHOLSON ML. The two layer method does not improve the preservation of porcine kidneys[J]. Med Sci Monit, 2011, 17(1): BR27-BR33. DOI: 10.12659/msm.881326.
    [38]
    MATTON APM, BURLAGE LC, VAN RIJN R, et al. Normothermic machine perfusion of donor livers without the need for human blood products[J]. Liver Transpl, 2018, 24(4): 528-538. DOI: 10.1002/lt.25005.
    [39]
    BHATTACHARJEE RN, PATEL SVB, SUN Q, et al. Renal protection against ischemia reperfusion injury: hemoglobin-based oxygen carrier-201 versus blood as an oxygen carrier in ex vivo subnormothermic machine perfusion[J]. Transplantation, 2020, 104(3): 482-489. DOI: 10.1097/TP.0000000000002967.
    [40]
    MAHBOUB P, ABURAWI M, KARIMIAN N, et al. The efficacy of HBOC-201 in ex situ gradual rewarming kidney perfusion in a rat model[J]. Artif Organs, 2020, 44(1): 81-90. DOI: 10.1111/aor.13534.
    [41]
    THUILLIER R, DUTHEIL D, TRIEU MT, et al. Supplementation with a new therapeutic oxygen carrier reduces chronic fibrosis and organ dysfunction in kidney static preservation[J]. Am J Transplant, 2011, 11(9): 1845-1860. DOI: 10.1111/j.1600-6143.2011.03614.x.
    [42]
    MALLET V, DUTHEIL D, POLARD V, et al. Dose-ranging study of the performance of the natural oxygen transporter HEMO2 Life in organ preservation[J]. Artif Organs, 2014, 38(8): 691-701. DOI: 10.1111/aor.12307.
    [43]
    TEH ES, ZAL F, POLARD V, et al. HEMO2life as a protective additive to Celsior solution for static storage of donor hearts prior to transplantation[J]. Artif Cells Nanomed Biotechnol, 2017, 45(4): 717-722. DOI: 10.1080/21691401.2016.1265974.
    [44]
    GLORION M, POLARD V, FAVEREAU F, et al. Prevention of ischemia-reperfusion lung injury during static cold preservation by supplementation of standard preservation solution with HEMO2life® in pig lung transplantation model[J]. Artif Cells Nanomed Biotechnol, 2018, 46(8): 1773-1780. DOI: 10.1080/21691401.2017.1392315.
    [45]
    KASIL A, GIRAUD S, COUTURIER P, et al. Individual and combined impact of oxygen and oxygen transporter supplementation during kidney machine preservation in a porcine preclinical kidney transplantation model[J]. Int J Mol Sci, 2019, 20(8): 1992. DOI: 10.3390/ijms20081992.
    [46]
    KAMINSKI J, HANNAERT P, KASIL A, et al. Efficacy of the natural oxygen transporter HEMO2 life® in cold preservation in a preclinical porcine model of donation after cardiac death[J]. Transpl Int, 2019, 32(9): 985-996. DOI: 10.1111/tri.13434.
    [47]
    FONTES P, LOPEZ R, VAN DER PLAATS A, et al. Liver preservation with machine perfusion and a newly developed cell-free oxygen carrier solution under subnormothermic conditions[J]. Am J Transplant, 2015, 15(2): 381-394. DOI: 10.1111/ajt.12991.
    [48]
    KHAN F, SINGH K, FRIEDMAN MT. Artificial blood: the history and current perspectives of blood substitutes[J]. Discoveries (Craiova), 2020, 8(1): e104. DOI: 10.15190/d.2020.1.
    [49]
    LE MEUR Y, BADET L, ESSIG M, et al. First-in-human use of a marine oxygen carrier (M101) for organ preservation: a safety and proof-of-principle study[J]. Am J Transplant, 2020, 20(6): 1729-1738. DOI: 10.1111/ajt.15798.
    [50]
    何晓顺, 鞠卫强, 朱泽斌. "无缺血"器官移植时代的来临与展望[J/CD]. 中华普通外科学文献(电子版), 2018, 12(2): 73-75. DOI: 10.3877/cma.j.issn.1674-0793.2018.02.001.

    HE XS, JU WQ, ZHU ZB. The coming and prospect of the era of "no ischemic" organ transplantation[J/CD]. Chin Arch Gen Surg (Electr Edit), 2018, 12(2): 73-75. DOI: 10.3877/cma.j.issn.1674-0793.2018.02.001.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (355) PDF downloads(91) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return